Navigation Links
NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity
Date:9/18/2007

and Ira Leon Rennert Professor of Aging Research at Einstein, as well as professor of medicine and of molecular genetics. We have in place a strong interdisciplinary team of Einstein investigators, including specialists in the fields of gerontology, neurology, genetics, epidemiology, and statistical genetics. These exceptional individuals have collaborated on our previous longevity research and we will continue our work together in this critical next phase, afforded by the NIH grant.

He added, Ultimately, our goal is to learn, on a biomechanical and molecular basis, how to prevent heart disease, strokes, dementia, and other ailments associated with aging. We anticipate that these insights could lead to new modes of prevention against and treatment strategies for these diseases. As such, we believe that our research will have a profound impact on both the length and quality of life for all of us.


'/>"/>

Contact: Karen Gardner
kgardner@aecom.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Aussie Nobel Prize Winners Receive Their Awards
2. Prestigious Gairdner Awards for medical research in 2006 Goes To Two Yale biologists
3. The President Gives Away National Disability Awards
4. Majority of Padma Awards Go to Doctors from Delhi
5. US, Indian Doctors Bag Thai Medical Awards
6. WHO Awards Prequalification Status to the First UAE Approved Vaccine
7. Bio-Rad Gets Life Science Industry Awards – 200
8. Michael J. Fox Foundation Awards $710,000 to Understanding of Parkinsons Disease Subtypes
9. Ontario Court Awards Compensation To Paralyzed Worker
10. Talwalkars Awards a Record $1 Million Order to Nautilus
11. NIH Awards Emory $3.6 Million for Schizophrenia Gene Research
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 2ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 3Masimo to Report Second Quarter 2009 Financial Results on August 4 2009 52366 1Masimo to Report Second Quarter 2009 Financial Results on August 4 2009 52366 2Masimo to Report Second Quarter 2009 Financial Results on August 4 2009 52366 3Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 1Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 2Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 3Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 4Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 5Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 6NBTY Acquisition of Julian Graves Unconditionally Cleared 52360 1NBTY Acquisition of Julian Graves Unconditionally Cleared 52360 2NBTY Acquisition of Julian Graves Unconditionally Cleared 52360 3NBTY Acquisition of Julian Graves Unconditionally Cleared 52360 4NBTY Acquisition of Julian Graves Unconditionally Cleared 52360 5